SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
SAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced ...
The COVID-19 pandemic has enabled consumers to perform rapid self-tests in the comfort of their homes, a convenient option that test makers like Abbott Laboratories, Becton Dickinson and Quidel are ...
The QuickVue® At-Home COVID-19 Test employs the same Quidel lateral flow technology used for decades by healthcare professionals and features the same SARS CoV-2 rapid antigen test strip and reagent ...
San Diego’s Quidel Corp. got the green light this week for its home-use COVID-19 diagnostic test with a prescription — an incremental step toward the company’s goal of offering rapid COVID tests over ...
After a bit of a rough patch, things are looking up for Quidel and its diagnostic offerings. The San Diego-based company snagged a CE mark for its Savanna molecular testing platform and the first ...
The FDA granted emergency use authorization March 1 to Quidel’s at-home COVID-19 antigen test. The Quidel QuickVue At-Home COVID-19 Test is authorized for prescription use and doesn’t require test ...
San Diego’s Quidel Corp. boosted its fourth quarter sales forecast on Thursday after the omicron and delta variants sparked increased demand for its rapid at-home COVID-19 tests. The company, which ...
A new at-home COVID test has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA). Below is what you need to know about the at-home test. How can I get a Quidel ...
Rival Abbott is looking to become the dominant player in the coronavirus test arena. Quidel fell the most because its COVID-19 test, the Sofia SARS Antigen FIA, is in the same class as Abbott's ...
These two diagnostics companies are trying to cash in on demand for coronavirus tests. Still, the companies are at significantly different phases in their life cycles. Guardant has yet to reach ...
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results